<?xml version="1.0" encoding="UTF-8"?>
<p id="Par2">Dengue is one of the fastest spreading mosquito-borne diseases worldwide. Annually, 390 million people become infected with one of four serologically distinct serotypes of dengue virus (DENV-1 to -4), through the bites of infected females of 
 <italic>Aedes aegypti</italic>
 <sup>
  <xref ref-type="bibr" rid="CR1">1</xref>,
  <xref ref-type="bibr" rid="CR2">2</xref>
 </sup>. This neglected tropical disease (NTD) has shown a 30-fold increase in global incidence over the past 50 years, including its severe form, dengue haemorrhagic fever
 <sup>
  <xref ref-type="bibr" rid="CR3">3</xref>
 </sup> and prospective studies have already predicted a dramatic increase of dengue in the following 30 years
 <sup>
  <xref ref-type="bibr" rid="CR4">4</xref>
 </sup>. The constant increase of dengue risk and dengue epidemics has been the target of a number of studies
 <sup>
  <xref ref-type="bibr" rid="CR5">5</xref>,
  <xref ref-type="bibr" rid="CR6">6</xref>
 </sup> but dengue transmission dynamics can be highly heterogeneous due to the complex interactions among virus serotypes, vector, and host.
</p>
